Er‐Bin Zhang
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Peroxisome Proliferator-Activated Receptors 1
- Ubiquitin and proteasome pathways 1
- Phytochemical compounds biological activities 1
- TGF-β signaling in diseases 1
- Metabolism, Diabetes, and Cancer 1
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Dong Xie (8 shared papers)Ning Ma (7 shared papers)Jing‐Jing Li (5 shared papers)Yanmei Yuan (4 shared papers)Tianwei Chen (5 shared papers)Shuqun Cheng (5 shared papers)Yabo Jiang (2 shared papers)Lin Qiu (3 shared papers)
- Journals
- Oncogene (3 papers)Nature Communications (1 paper)Biochemical and Biophysical Research Communications (1 paper)Hepatology (1 paper)Cellular Physiology and Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Er‐Bin Zhang
8 papers receiving 289 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 93
- Hepatology 34
- Molecular Biology 172
- Oncology 47
- Cell Biology 21
Countries citing papers authored by Er‐Bin Zhang
This map shows the geographic impact of Er‐Bin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Er‐Bin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Er‐Bin Zhang more than expected).
Fields of papers citing papers by Er‐Bin Zhang
This network shows the impact of papers produced by Er‐Bin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Er‐Bin Zhang. The network helps show where Er‐Bin Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Er‐Bin Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 65 | |
| 2 | 2015 | 57 | |
| 3 | 2016 | 52 | |
| 4 | 2019 | 36 | |
| 5 | 2018 | 36 | |
| 6 | 2021 | 21 | |
| 7 | 2019 | 14 | |
| 8 | 2022 | 12 |
About Er‐Bin Zhang
Er‐Bin Zhang is a scholar working on Molecular Biology, Cancer Research, Oncology, Organic Chemistry and Surgery, having authored 8 papers that have together received 293 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Click Chemistry and Applications (1 paper), Ubiquitin and proteasome pathways (1 paper), Fungal Biology and Applications (1 paper), Phytochemical compounds biological activities (1 paper), TGF-β signaling in diseases (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Cancer Research (93 citations), Hepatology (34 citations), Molecular Biology (172 citations), Oncology (47 citations) and Cell Biology (21 citations). Er‐Bin Zhang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Dong Xie, Ning Ma, Jing‐Jing Li, Yanmei Yuan, Tianwei Chen, Shuqun Cheng, Yabo Jiang, Lin Qiu, Cheng‐Qian Zhong and Dongxian Guan. Their work appears in journals such as Oncogene, Nature Communications, Biochemical and Biophysical Research Communications, Hepatology and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.